VSEE HEALTH, INC.VSEEEarnings & Financial Report
VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.
Revenue
$3.3M
Gross Profit
$1.9M
Operating Profit
$-1.8M
Net Profit
$-4.0M
Gross Margin
56.0%
Operating Margin
-55.1%
Net Margin
-119.2%
YoY Growth
104.9%
EPS
$-0.24
VSEE HEALTH, INC. Q1 FY2025 Financial Summary
VSEE HEALTH, INC. reported revenue of $3.3M (up 104.9% YoY) for Q1 FY2025, with a net profit of $-4.0M (down 6407.9% YoY) (-119.2% margin). Cost of goods sold was $1.5M, operating expenses totaled $3.7M.
Key Financial Metrics
| Total Revenue | $3.3M |
|---|---|
| Net Profit | $-4.0M |
| Gross Margin | 56.0% |
| Operating Margin | -55.1% |
| Report Period | Q1 FY2025 |
Revenue Breakdown
VSEE HEALTH, INC. Q1 FY2025 revenue of $3.3M breaks down across 2 segments, led by Technology Segment at $2.1M (63.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Technology Segment | $2.1M | 63.9% |
| Telehealth Segment | $1.2M | 36.1% |
VSEE HEALTH, INC. Annual Revenue by Year
VSEE HEALTH, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $14.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $14.6M |
| 2024 | $10.4M |
| 2023 | $5.8M |
VSEE HEALTH, INC. Quarterly Revenue & Net Profit History
VSEE HEALTH, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.9M | +5.1% | $-7.9M | -200.0% |
| Q3 FY2025 | $4.0M | +18.7% | $-289.7K | -7.3% |
| Q2 FY2025 | $3.4M | +98.1% | $-2.6M | -77.1% |
| Q1 FY2025 | $3.3M | +104.9% | $-4.0M | -119.2% |
| Q4 FY2024 | $3.7M | +151.6% | $-3.2M | -85.9% |
| Q3 FY2024 | $3.4M | +134.1% | $-53.9M | -1607.5% |
| Q2 FY2024 | $1.7M | +34.6% | $-634.1K | -37.0% |
| Q1 FY2024 | $1.6M | +2.8% | $62.8K | 3.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6M | $1.7M | $3.4M | $3.7M | $3.3M | $3.4M | $4.0M | $3.9M |
| YoY Growth | 2.8% | 34.6% | 134.1% | 151.6% | 104.9% | 98.1% | 18.7% | 5.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.4M | $78.6M | $22.3M | $20.0M | $19.4M | $18.2M | $18.7M | $22.4M |
| Liabilities | $5.6M | $25.5M | $21.4M | $20.0M | $22.9M | $23.9M | $24.3M | $17.0M |
| Equity | $-13.2M | $53.1M | $933128 | $-18488 | $-3.5M | $-5.7M | $-5.6M | $5.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $579286 | $-3.2M | $-221034 | $-3.0M | $-440493 | $-324601 | $-754538 | $-1.9M |